Matthews Judith M. 4
4 · Iterum Therapeutics plc · Filed Oct 2, 2020
Insider Transaction Report
Form 4
Matthews Judith M.
Chief Financial Officer
Transactions
- Sale
Ordinary Shares
2020-09-30$1.64/sh−56,130$92,053→ 0 total
Footnotes (1)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2020.